Last reviewed · How we verify
NCT04774341
Personalized Evidence-based Medicine in Patients With Atrial Fibrillation
trial testing anticoagulation treatment in Adherence to Personalized EBM Anticoagulant Treatment in Patients at High Risk for Stroke in 4,200 participants. Completed in 24 February 2021.
24 February 2021
Quick facts
| Lead sponsor | Center of Personalized Medicine, Pirogova |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 4,200 |
| Start date | 10 January 2021 |
| Primary completion | 24 February 2021 |
| Estimated completion | 24 February 2021 |
| Sites | 1 location across Russia |
Drugs / interventions tested
- anticoagulation treatment
Conditions studied
- Adherence to Personalized EBM Anticoagulant Treatment in Patients at High Risk for Stroke — all drugs for Adherence to Personalized EBM Anticoagulant Treatment in Patients at High Risk for Stroke →
Sponsor
Center of Personalized Medicine, Pirogova — full company profile →
Who can join
Eligibility, any sex, with Adherence to Personalized EBM Anticoagulant Treatment in Patients at High Risk for Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A retrospective analysis
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04774341
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Center of Personalized Medicine, Pirogova trials
Trials by the same sponsor.
- NCT04802941 — Neoadjuvant Chemotherapy in Breast Cancer · NA · unknown
- NCT04798976 — Personalized Evidence-based Treatment in Patients With Invasive Breast Cancer · unknown
- NCT04791046 — Antihypertensive Therapy in Patients With Comorbidities · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04774341 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Center of Personalized Medicine, Pirogova
- Last refreshed: 2 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04774341.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing